Shannon E. Best

Herston, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.

Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.

Journal: Clinical & translational immunology
Published: January 31, 2025

Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis.

Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis.

Journal: Clinical & translational immunology
Published: September 08, 2024

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Journal: Nature communications
Published: May 31, 2024

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants.

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants.

Journal: PLoS pathogens
Published: December 17, 2021

Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis.

Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis.

Journal: Cell reports
Published: April 22, 2019

Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection.

Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 05, 2017

IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage Plasmodium Infection.

IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage Plasmodium Infection.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 01, 2017

Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.

Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.

Journal: International journal for parasitology
Published: January 17, 2017

IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.

IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.

Journal: PLoS pathogens
Published: June 10, 2016

Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection.

Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection.

Journal: Cell reports
Published: April 06, 2016

Correction: Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.

Correction: Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.

Journal: PLoS pathogens
Published: February 13, 2016

Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.

Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.

Journal: PLoS pathogens
Published: September 15, 2015
Showing 1-12 of 22

Last Updated: 09/26/2026